Navigation Links
Socioeconomic Status Plays A Role In Juvenile Rheumatoid Arthritis

A group of autoimmune diseases, named Juvenile rheumatoid arthritis (JRA), causes chronic inflammation of the joints, which inversely affect health-related quality of life// , during adulthood. Socioeconomic status suggests patient prognosis in adults – study finds. But nothing regarding children was found.

Arthritis Care & Research journal published a study in the June 2006 issue, which examined the relationship between patient health insurance coverage (as an indicator of socioeconomic status) and disease outcomes for children with JRA and found that those on Medicaid had significantly lower health-related quality of life (HRQOL) and higher disability than who doesn’t have.

Led by Hermine I. Brunner, Janalee Taylor and Murray Passo of the Cincinnati Children's Hospital Medical Center in Cincinnati, Ohio, researchers assessed children with JRA who were seen at the hospital's rheumatology clinic between July 2003 and March 2004. Medicaid coverage (or similar coverage under state programs for low-income families of children with chronic diseases) was considered to be an indicator of low socioeconomic status, while having private insurance was considered to be an indicator of middle to high socioeconomic status.

Children were evaluated based on age, disease duration, type of JRA onset, course of the disease, number of joints affected, current disease activity, pain, disability and HRQOL. Health care resource utilization was also assessed based on billing for events such as radiology testing, laboratory testing, clinic visits, and inpatient care.

The findings showed that there was a trend toward a higher number of joints affected by arthritis in the Medicaid group, which comprised 40 (14%) of the 295 children evaluated. They also had somew hat higher disease activity, more pain, and a lower level of well-being than children with private health insurance.

In addition, the Medicaid group had higher disability and a lower proportion of children with normal physical function, although they had similar access to health care services compared to the privately insured children. ‘Similar to results found in studies of other pediatric diseases, the results of this study support the theory that Medicaid status is associated with more disability and lower HRQOL, even in the absence of apparent differences in health care resource utilization,’ the authors state. They add that these differences are not only statistically significant, but clinically significant as well.

The reasons why insurance status is associated with disability and HRQOL in JRA is not clear, since health care resource utilization did not appear to be affected by the type of health insurance the children were using. The authors hypothesize that non-treatment-related factors such as poverty and non-adherence to prescribed treatments might account in part for the differences seen between the Medicaid versus the privately insured children.

‘We believe the current study is the first to document a clinically important association between patient insurance status and disease outcome in JRA,’ the authors conclude. Further studies are needed to determine the mechanisms that lead to the differences observed in the two groups, and to determine whether access to and utilization of health care resources are truly equitable in patients with different health insurance status.

Source: Eurekaert
'"/>




Related medicine news :

1. Low Socioeconomic Status May Lead To Mental Illness
2. Prostate Cancer Outcomes Determined By Socioeconomic Status
3. Hormone Levels Increase Due To Socioeconomic Stress
4. Age and Socioeconomic Factors Are Strongest Determinants of Sunburn
5. Status of some prescription drugs
6. Low Socioeconomic Status May Lead To Mental Illness
7. Post-Menopausal Status May Cause Tooth Decay
8. Ruling On Non Disclosure Of HIV Positive Status Is Not Ethical
9. Treatment For Prostate Cancer Relapse Linked To Marital Status
10. Study Finds Low Socio-Economic Status Linked to Poor Dental Health
11. Prostate Cancer Outcomes Determined By Socioeconomic Status
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
(Date:6/24/2016)... Frederick, Maryland (PRWEB) , ... June 24, 2016 ... ... Mid-Atlantic Angels is actively feeding the Frederick area economy by obtaining investment capital ... support over the past 2½ years that have already resulted in more than ...
(Date:6/24/2016)... ... 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The ... members that have been wounded in battle and their families. Venture Construction Group is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Advanced Plastic Surgery ... Arizona pageant as its official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic ... , Dr. Olson says the decision to support the pageant in an ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based ... however, are unsure how to move forward, given the need to sustain current ... forward tailored to an organization’s specific needs. , PYA Principal Martie Ross states, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: